Literature DB >> 2803942

Tumour hypoglycaemia: raised tumour IGFII mRNA associated with reduced plasma somatomedins.

P N Schofield1, H Connor, R C Turner, J Zapf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803942      PMCID: PMC2247299          DOI: 10.1038/bjc.1989.335

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  18 in total

1.  Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution.

Authors:  V K Han; P K Lund; D C Lee; A J D'Ercole
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

2.  Amino acid sequence of a variant pro-form of insulin-like growth factor II.

Authors:  P P Zumstein; C Lüthi; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Nucleotide sequence of a cDNA clone encoding human preproinsulin.

Authors:  G I Bell; W F Swain; R Pictet; B Cordell; H M Goodman; W J Rutter
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

4.  Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level.

Authors:  G K Haselbacher; J C Irminger; J Zapf; W H Ziegler; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Stimulatory effects of insulin-like growth factors on DNA synthesis in the human embryonic cornea.

Authors:  L Hyldahl; W Engström; P N Schofield
Journal:  J Embryol Exp Morphol       Date:  1986-11

6.  Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.

Authors:  W H Daughaday; M A Emanuele; M H Brooks; A L Barbato; M Kapadia; P Rotwein
Journal:  N Engl J Med       Date:  1988-12-01       Impact factor: 91.245

7.  Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas.

Authors:  J V Tricoli; L B Rall; C P Karakousis; L Herrera; N J Petrelli; G I Bell; T B Shows
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

8.  Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues.

Authors:  J Scott; J Cowell; M E Robertson; L M Priestley; R Wadey; B Hopkins; J Pritchard; G I Bell; L B Rall; C F Graham
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

9.  Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours.

Authors:  J W Höppener; S Mosselman; P J Roholl; C Lambrechts; R J Slebos; P de Pagter-Holthuizen; C J Lips; H S Jansz; J S Sussenbach
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

10.  Regulation of human IGF-II transcription in fetal and adult tissues.

Authors:  P N Schofield; V E Tate
Journal:  Development       Date:  1987-12       Impact factor: 6.868

View more
  5 in total

1.  Symptomatic hypoglycemia related to inappropriately high igf-ii serum levels in a patient with desmoplastic small round cell tumor.

Authors:  Williams Fernandes Barra; Gilberto Castro; Ana Oliveira Hoff; Sheila A C Siqueira; Paulo M Hoff
Journal:  Case Rep Med       Date:  2010-06-02

2.  Tumour-associated hypoglycaemia in a murine cachexia model.

Authors:  T M McDevitt; M J Tisdale
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

Review 3.  Insulin-like growth factors and cancer.

Authors:  V M Macaulay
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

4.  Tumour suppression associated with expression of human insulin-like growth factor II.

Authors:  P N Schofield; A Lee; D J Hill; J E Cheetham; D James; C Stewart
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

5.  The role of insulin-like growth factor system in soft tissue sarcomas: from physiopathology to targeted therapeutic approaches.

Authors:  W Zumkeller
Journal:  Sarcoma       Date:  1998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.